CAPNIA CoSense ETCOc Monitor
CAPNIA CoSense ETCOc Monitoring and Indicating Devices
Please Contact Your Local Sales Rep About Pricing & Availability
Jaundice management is complex, but improving outcomes is easier than you think with CoSense® ETCOc testing. A simple breath test provides early and accurate measurement of hemolysis and neurotoxic risk that can lead to hemolytic hyperbilirubinemia (HB) and kernicterus. View Our CAPNIA CoSense Brochure >
CoSense is the “Gold Standard” Test for Diagnosing & Quantifying Hemolysis in Neonates and Infants
- Supports Best Practices. AAP Recommends the Use of ETCOc
- 15-30 Seconds to collect a breath sample with the CoSense® ETCOc Monitor
- 100% Simple and non-Invasive
- <5 Minutes for the CoSense® ETCOc Monitor to analyze the baby’s breath sample and accurately measure hemolysis; performed at the bedside with results in <5 minute
- 3 Easy Steps to operate and no calibration required
- 50% Decrease in blood tests on newborns for managing hyperbilirubinemia
- 20% Decrease in phototherapy and improved utilization
- $200K Savings from the 50% decrease in blood tests on newborns (University of Utah, 2021 Study)
- Decreased readmissions
- Decreased length of stay in the hospital
View All ETCOc Monitoring & Indicating Devices from HCT
CoSense End Tidal CO Monitor Device
The CoSense® ETCOc Monitor analyzes the baby’s breath sample and accurately measure hemolysis; performed at the bedside with results in <5 minutes.
CoSense Precision Sampling Set for the End Tidal CO Monitor
This single-use sampling set is simply applied to the patient to analyze and measure measure hemolysis back to the monitor for testing.
Rolling Stand for CoSense Monitor
Specifically designed to securely mount the CoSense Monitor for easy access and availability.